TransDigm Group’s (TDG) Buy Rating Reaffirmed at Barclays

Share on StockTwits

Barclays reiterated their buy rating on shares of TransDigm Group (NYSE:TDG) in a report released on Wednesday, AnalystRatings.com reports.

Several other research firms also recently commented on TDG. Credit Suisse Group increased their price objective on TransDigm Group from $476.00 to $539.00 and gave the company an outperform rating in a research note on Wednesday, May 8th. Canaccord Genuity reissued a buy rating and issued a $520.00 price objective (up from $460.00) on shares of TransDigm Group in a research note on Wednesday, May 8th. JPMorgan Chase & Co. increased their price objective on TransDigm Group from $465.00 to $515.00 and gave the company an underweight rating in a research note on Tuesday. Longbow Research assumed coverage on TransDigm Group in a research note on Tuesday, April 9th. They issued a neutral rating for the company. Finally, Zacks Investment Research raised TransDigm Group from a hold rating to a buy rating and set a $513.00 price objective for the company in a research note on Tuesday, April 16th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and ten have assigned a buy rating to the company. The stock has a consensus rating of Buy and a consensus target price of $454.64.

NYSE TDG traded up $9.21 during mid-day trading on Wednesday, hitting $461.84. The stock had a trading volume of 3,532 shares, compared to its average volume of 360,243. TransDigm Group has a twelve month low of $307.36 and a twelve month high of $489.95. The company has a market cap of $24.28 billion, a P/E ratio of 27.20, a P/E/G ratio of 1.97 and a beta of 1.01.

TransDigm Group (NYSE:TDG) last posted its quarterly earnings data on Tuesday, May 7th. The aerospace company reported $4.21 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.73 by $0.48. TransDigm Group had a negative return on equity of 50.29% and a net margin of 19.44%. The firm had revenue of $1.20 billion during the quarter, compared to the consensus estimate of $1.11 billion. During the same period in the prior year, the company earned $3.79 EPS. The firm’s revenue was up 28.2% compared to the same quarter last year. On average, research analysts predict that TransDigm Group will post 16.12 EPS for the current fiscal year.

In other news, EVP Jorge Valladares sold 5,000 shares of the stock in a transaction on Tuesday, February 19th. The stock was sold at an average price of $436.99, for a total transaction of $2,184,950.00. Following the completion of the transaction, the executive vice president now directly owns 14,000 shares in the company, valued at approximately $6,117,860. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Robert J. Small purchased 229,940 shares of the stock in a transaction dated Wednesday, February 20th. The shares were acquired at an average price of $434.90 per share, with a total value of $100,000,906.00. Following the completion of the acquisition, the director now owns 37,175 shares in the company, valued at approximately $16,167,407.50. The disclosure for this purchase can be found here. Over the last 90 days, insiders sold 69,793 shares of company stock valued at $31,178,900. 11.00% of the stock is owned by company insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Lenox Wealth Management Inc. purchased a new position in TransDigm Group during the 1st quarter valued at about $25,000. Bremer Bank National Association purchased a new position in TransDigm Group during the 1st quarter valued at about $32,000. Cresset Asset Management LLC purchased a new position in TransDigm Group during the 1st quarter valued at about $38,000. Marshall Wace LLP purchased a new position in TransDigm Group during the 1st quarter valued at about $47,000. Finally, Pinnacle Bank purchased a new position in TransDigm Group during the 4th quarter valued at about $37,000.

About TransDigm Group

TransDigm Group Incorporated designs, produces, and supplies aircraft components in the United States and internationally. The company operates in three segments: Power & Control, Airframe, and Non-aviation. The Power & Control segment offers mechanical/electro-mechanical actuators and controls, ignition systems and engine technology, specialized pumps and valves, power conditioning devices, specialized AC/DC electric motors and generators, databus and power controls, hoists, winches and lifting devices, and cargo loading and handling systems.

See Also: The Structure of a Futures Contract

Analyst Recommendations for TransDigm Group (NYSE:TDG)

Receive News & Ratings for TransDigm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransDigm Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Atara Biotherapeutics  Now Covered by Stifel Nicolaus
Atara Biotherapeutics Now Covered by Stifel Nicolaus
Critical Contrast: MFC Bancorp  and Bancolombia
Critical Contrast: MFC Bancorp and Bancolombia
Paragon Banking Group’s  Hold Rating Reiterated at Numis Securities
Paragon Banking Group’s Hold Rating Reiterated at Numis Securities
Short Interest in Moleculin Biotech Inc  Grows By 327.4%
Short Interest in Moleculin Biotech Inc Grows By 327.4%
OrganiGram  Sets New 52-Week High at $11.30
OrganiGram Sets New 52-Week High at $11.30
Weekly Analysts’ Ratings Changes for Seres Therapeutics
Weekly Analysts’ Ratings Changes for Seres Therapeutics


© 2006-2019 Ticker Report